[Paralytic ileus with fatal consequence under psychotropic medication].
Ingo Runte1, Ulrich Hamberger2
1Klinik für Psychiatrie und Psychotherapie, Evangelisches Klinikum Bethel, Bielefeld.
Fortschritte Der Neurologie-Psychiatrie
|June 24, 2017
Summary
Psychotropic medications, often used for psychotic disorders, can cause fatal paralytic ileus due to their anticholinergic effects. This study highlights the need for therapeutic strategies to prevent such adverse drug events.
Area of Science:
- Pharmacology
- Clinical Medicine
- Psychiatry
Background:
- Psychotic disorders are often treated with long-term psychotropic medication.
- Anticholinergic side effects are a known concern with some psychotropic drugs.
Observation:
- A cluster of four deaths from paralytic ileus occurred in Bielefeld over two years.
- All deceased patients had psychotic disorders and long-term psychotropic drug use.
Findings:
- Paralytic ileus was identified as the cause of death after excluding other factors.
- The anticholinergic effects of psychotropic medications were implicated in these fatalities.
Implications:
- Review of literature and receptor profiles supports the link between anticholinergic effects and paralytic ileus.
- Therapeutic interventions are proposed to mitigate the risk of fatal paralytic ileus in patients on psychotropic medications.
Related Concept Videos
01:26Psychosis: Goals of Pharmacotherapy
642
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
642
01:17Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
773
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
773
01:26Anticholinesterase Agents: Poisoning and Treatment
1.8K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.8K
01:17Drugs for Treatment of Diarrhea-Predominant IBS
798
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
798
01:14Prevention of Further Absorption of Poison
1.3K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.3K
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
1.5K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.5K